Author
Listed:
- Yongqing Liu
(Molecular Targets Program, James Brown Cancer Center, University of Louisville Health Sciences Center
University of Louisville Health Sciences Center
Birth Defects Center, University of Louisville Health Sciences Center)
- Ester Sánchez-Tilló
(Group of Transcriptional Regulation of Gene Expression, CIBERehd, IDIBAPS)
- Xiaoqin Lu
(University of Louisville Health Sciences Center)
- Brian Clem
(Molecular Targets Program, James Brown Cancer Center, University of Louisville Health Sciences Center)
- Sucheta Telang
(Molecular Targets Program, James Brown Cancer Center, University of Louisville Health Sciences Center)
- Alfred B. Jenson
(Molecular Targets Program, James Brown Cancer Center, University of Louisville Health Sciences Center)
- Miriam Cuatrecasas
(Hospital Clinic)
- Jason Chesney
(Molecular Targets Program, James Brown Cancer Center, University of Louisville Health Sciences Center)
- Antonio Postigo
(Molecular Targets Program, James Brown Cancer Center, University of Louisville Health Sciences Center
Group of Transcriptional Regulation of Gene Expression, CIBERehd, IDIBAPS
ICREA)
- Douglas C. Dean
(Molecular Targets Program, James Brown Cancer Center, University of Louisville Health Sciences Center
University of Louisville Health Sciences Center
Birth Defects Center, University of Louisville Health Sciences Center)
Abstract
It is thought that genomic instability precipitated by Rb1 pathway loss rapidly triggers additional cancer gene mutations, accounting for rapid tumour onset following Rb1 mutation. However, recent whole-genome sequencing of retinoblastomas demonstrated little genomic instability, but instead suggested rapid epigenetic activation of cancer genes. These results raise the possibility that loss of the Rb1 pathway, which is a hallmark of cancers, might be sufficient for cancer initiation. Yet, mutation of the Rb1 family or inactivation of the Rb1 pathway in primary cells has proven insufficient for tumour initiation. Here we demonstrate that traditional nude mouse assays impose an artificial anoikis and proliferation barrier that prevents Rb1 family mutant fibroblasts from initiating tumours. By circumventing this barrier, we show that primary fibroblasts with only an Rb1 family mutation efficiently form sarcomas in nude mice, and a Ras-ZEB1-Akt pathway then causes transition of these tumours to an invasive phenotype.
Suggested Citation
Yongqing Liu & Ester Sánchez-Tilló & Xiaoqin Lu & Brian Clem & Sucheta Telang & Alfred B. Jenson & Miriam Cuatrecasas & Jason Chesney & Antonio Postigo & Douglas C. Dean, 2013.
"Rb1 family mutation is sufficient for sarcoma initiation,"
Nature Communications, Nature, vol. 4(1), pages 1-10, December.
Handle:
RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms3650
DOI: 10.1038/ncomms3650
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms3650. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.